Theodore Alexandrov is an Assistant Professor in the Departments of Pharmacology and Bioengineering at the University of California, San Diego (UCSD). Previously, he led a team at the European Molecular Biology Laboratory (EMBL), where he established and directed the EMBL Metabolomics Core Facility and served as a faculty member of the Molecular Medicine Partnership Unit between EMBL and Heidelberg University.

At UCSD, Theodore Alexandrov leads a multidisciplinary team of scientists and software engineers focused on developing cutting-edge technologies for spatial and single-cell metabolomics. Their mission is to tackle critical biological, medical, and pharmacological challenges. The team integrates experimental and computational expertise with software engineering, leveraging both individual and collective knowledge to support collaborators and the broader scientific community in addressing pressing scientific questions (https://ateam.ucsd.edu).

Under his leadership, the team has published over 100 peer-reviewed journal articles and holds multiple patents. Among their notable achievements are the development of METASPACE, an open-source big data cloud platform for spatial metabolomics, and SpaceM, a pioneering method for spatial single-cell metabolomics.

An experienced entrepreneur, Theodore Alexandrov actively engages in industrial collaborations. He co-founded and served as the scientific director of SCiLS, a startup specializing in software solutions for imaging mass spectrometry. Since 2021, he has been spearheading the creation of a startup-in-incubation at the BioInnovation Institute in Copenhagen, Denmark, with the goal of commercializing an innovative single-cell metabolomics platform for drug discovery and therapy development.